Aplicación de la farmacoeconomía a los resultados de la medicación para la curación de las úlceras pépticas

a comparative economic evaluation of the costs of chemotherapeutic treatments of 3 anti-ulcer schemes (ranitidine, omeprazol and cimetidine), as well as the cost-effectiveness analysis were made to determine the most convenient drug combination for the cicatrization of peptic ulcer and for the erradication of its causal agent, helicobacter pylori, from the economic and technical point of view. as a result, it was obtained a combined chemotherapeutic scheme for different cycles of time in the anti-ulcer treatments (ranitidine-omeprazol) that increases the effectiveness and reduces the costs of drugs for the national health system.